| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | EP1228095B1 Modified gp100 and uses thereof |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP1036175B1 Human brain derived kcnq2 potassium channel |
| 04/09/2008 | EP0958287B2 Sulfamide-metalloprotease inhibitors |
| 04/09/2008 | CN101160137A Use of CD 25antibody in immunity treatment |
| 04/09/2008 | CN101160134A Selection and use of lactic acid bacteria for reducing inflammation in mammals |
| 04/09/2008 | CN101156947A Ginseng source peptide albumen, its preparing method and application |
| 04/09/2008 | CN101156936A An administer orally mixed nucleus glycosides as well as its preparing technics |
| 04/09/2008 | CN101156928A A Subhealth treating Chinese medicine composition and method of making the same |
| 04/09/2008 | CN101156919A Compositions of A-beta peptide and preparation method |
| 04/09/2008 | CN101156914A Method for extracting triterpenic acid from Chinese date dregs |
| 04/09/2008 | CN101156892A A preparation method of active component composition of antineoplastic improving phylactic power |
| 04/09/2008 | CN101156860A Use of mometasone furoate for treating airway passage and lung diseases |
| 04/09/2008 | CN100379865C Method and reagents for vaccination which generate a CD8 T cell immune response |
| 04/09/2008 | CN100379862C Method of promoting homologous recombination of somatic cells and method of constructing specific antibody |
| 04/09/2008 | CN100379855C Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 04/09/2008 | CN100379853C Genetic constructs and compositions comprising RRE and CTE and uses thereof |
| 04/09/2008 | CN100379850C Preparation method of ganoderma biological activity multivitamin intesifying agent |
| 04/09/2008 | CN100379759C Compounds for treatment of infectious and immune system disorders and method for their use |
| 04/09/2008 | CN100379750C Inhibitors of nucleoside phosphorylases and nucleosidases |
| 04/09/2008 | CN100379744C The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 04/09/2008 | CN100379742C New tricyclic derivatives as LTD4 antagonists |
| 04/09/2008 | CN100379734C Azaindoles |
| 04/09/2008 | CN100379719C Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 04/09/2008 | CN100379450C Method of expressing antigen on the surface of an antigen-presenting cell by photochemical internalisation |
| 04/09/2008 | CN100379448C 蛋白酶抑制剂 Protease inhibitors |
| 04/09/2008 | CN100379439C Health product for enhancing immunity and soothing the nerves |
| 04/09/2008 | CN100379438C Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation method |
| 04/09/2008 | CN100379427C Tablet auxiliary product for increase of body immunological competence |
| 04/09/2008 | CN100379359C Compound containing vinegar-egg powder and application thereof |
| 04/08/2008 | US7355063 Antioxidants; hyaluronic acid-degrading enzyme inhibitor; water solubility; useful in the fields of foods, medicines, quasi-drugs, cosmetics; analogous to shogaol and gingerol |
| 04/08/2008 | US7355017 Fusion polypeptide for use in the treatment and prevention of graft rejection |
| 04/08/2008 | US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
| 04/08/2008 | US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12 |
| 04/08/2008 | US7354939 Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354919 Isoxazole compositions useful as inhibitors of ERK |
| 04/08/2008 | US7354907 immunomer comprising two or more oligonucleotide branches linked together; can cause immune stimulation across species lines; less expensive to make |
| 04/08/2008 | US7354769 Comparing the ability of N,N-bis(3-D-gluconamidopropyl)-deoxycholamine to inhibit binding of IGFBP-1 or -3 to IGF-1 with the ability of a candidate indirect agonist of IGF-1 to identify effective agonists |
| 04/08/2008 | US7354737 peptide delivers biological response modifiers into cytoplasm, intracellular organelles or nucleus of prokaryotic/eukaryotic cells; use in drug delivery, vaccines, gene and protein therapy |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | CA2372962C Novel interleukin-1 and tumor necrosis factor-.alpha. modulators, syntheses of said modulators and methods of using said modulators |
| 04/08/2008 | CA2141953C Pharmaceutical formulations of interleukin-1 inhibitors |
| 04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2008039432A1 Compositions and methods for enhancing an adjuvant |
| 04/03/2008 | WO2008038846A1 A composition comprising complex crude drug extracts showing anti-allergic rhinitis, anti-atopic dermatitis and anti-asthma activity |
| 04/03/2008 | WO2008038711A1 Oxepin derivative |
| 04/03/2008 | WO2008038579A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 04/03/2008 | WO2008037476A1 Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties |
| 04/03/2008 | WO2008037421A2 Pharmaceutical compositions comprising an s1p modulator |
| 04/03/2008 | WO2008037419A1 Antibodies against ccr5 and uses thereof |
| 04/03/2008 | WO2008037080A1 Methods and compositions for immune response modulation and uses thereof |
| 04/03/2008 | WO2007086001A3 Novel pyridine derivatives |
| 04/03/2008 | US20080081838 Inhibition of TNF-alpha-Initiated Neutrophil Response |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081803 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 04/03/2008 | US20080081800 2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs |
| 04/03/2008 | US20080081799 2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs |
| 04/03/2008 | US20080081788 reduce the elevated level of free IgE in patient's serum by oral administering peptide biodrug; also can reduce nerve growth factor, myoglobin, Insulin, adenosine deaminase; treating asthma, type 2 diabetes, depression, autoimmune diseases, diabetes, Graves' disease, Addison's disease, Hodgkin's disease |
| 04/03/2008 | US20080081076 Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
| 04/03/2008 | US20080081043 Nucleotide sequences coding natural killer cell ligand for use as tool in treatment cell proliferative disorders |
| 04/03/2008 | CA2847852A1 Inhibitors of bruton's tyrosine kinase |
| 04/03/2008 | CA2664752A1 Antibodies against ccr5 and uses thereof |
| 04/03/2008 | CA2664345A1 Oxepin derivative |
| 04/03/2008 | CA2664310A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | CA2664268A1 Diaryl oxadiazol derivatives |
| 04/03/2008 | CA2663851A1 Compositions and methods for enhancing an adjuvant |
| 04/03/2008 | CA2662864A1 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 04/03/2008 | CA2662383A1 Organic compounds |
| 04/02/2008 | EP1905832A2 Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 04/02/2008 | EP1905766A1 Glycolipid derivative and therapeutic agent comprising the same as active ingredient |
| 04/02/2008 | EP1905763A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents |
| 04/02/2008 | EP1905762A1 Pyrazolone derivative |
| 04/02/2008 | EP1905457A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/02/2008 | EP1905449A2 Vaccines |
| 04/02/2008 | EP1905434A1 Organic compounds comprising an S1P receptor agonist and their therapeutic use |
| 04/02/2008 | EP1904531A2 Novel madcam antibodies |
| 04/02/2008 | EP1904478A1 Acid addition salts of n-ethyl-n'-[2-methoxy-4-(5-methyl-4-{[(1s)-1-pyridin-3-ylbutyl]amino}pyrimidin- 2-yl)phenyl]urea and uses thereof |
| 04/02/2008 | EP1904457A2 Compositions and methods for inhibition of the jak pathway |
| 04/02/2008 | EP1904451A1 Aryl-alkylamines and heteroaryl-alkylamines as protein kinase inhibitors |
| 04/02/2008 | EP1904105A2 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 04/02/2008 | EP1904103A2 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 04/02/2008 | EP1904101A2 Anti-cd19 antibody therapy for the transplantation |
| 04/02/2008 | EP1904057A2 Methods of treatment using hydroquinone ansamycins |
| 04/02/2008 | EP1904054A1 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 04/02/2008 | EP1904048A1 Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders |
| 04/02/2008 | EP1482959B1 Compositions for treatment of skin disorders |
| 04/02/2008 | EP1397153B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 04/02/2008 | EP1244466B1 ACTIVATION OF THE IMMUNE SYSTEM BY AN NF-kappaB INDUCER AND AN ANTIGEN |
| 04/02/2008 | EP1009824B1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-kappaB ACTIVATION |
| 04/02/2008 | CN101155829A High affinity HIV T cell receptors |
| 04/02/2008 | CN101155593A Use of iron(iii) complex compounds |
| 04/02/2008 | CN101153254A Health-care orange wine |
| 04/02/2008 | CN101152572A Preparations of monoclone antibody |
| 04/02/2008 | CN101152560A Segmented intestine target drug administration preparations of blood protein polypeptide and method for preparing the same |